NCT04295551View on ClinicalTrials.gov

Multicenter Clinical Study on the Efficacy and Safety of Xiyanping Injection in the Treatment of New Coronavirus Infection Pneumonia (General and Severe)

NAUnknownINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

March 14, 2020

Primary Completion Date

July 14, 2020

Study Completion Date

April 14, 2021

Conditions

COVID-19

Interventions

DRUG

Lopinavir / ritonavir tablets combined with Xiyanping injection

Xiyanping injection, 10-20ml daily, Qd, the maximum daily does not exceed 500mg (20mL) + Lopinavir tablet or Ritonavir tablet+Alpha-interferon nebulization, for 7-14 days,

DRUG

Lopinavir/ritonavir treatment

Lopinavir / ritonavir tablets, 2 times a day, 2 tablets at a time; alpha-interferon nebulization